# Pascal Hammel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pascal-hammel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,665 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 83 |
| i10-index | 257 |
| Last Known Institution | Université Paris-Saclay |
| OpenAlex ID | https://openalex.org/A5067073528 |
| ORCID iD | https://orcid.org/0000-0002-4630-4996 |
| Works | 662 |

## Researcher papers

- [Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/sunitinib-malate-for-the-treatment-of-pancreatic-neuroendocrine-tumors/)
- [Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies](https://scholariq.org/papers/impact-of-chemoradiotherapy-after-disease-control-with-chemotherapy-in-locally/)
- [The natural history of hereditary pancreatitis: a national series](https://scholariq.org/papers/the-natural-history-of-hereditary-pancreatitis-a-national-series/)
- [Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma](https://scholariq.org/papers/inter-and-intra-tumoural-heterogeneity-in-cancer-associated-fibroblasts-of-human/)
- [Pancreas Divisum Is Not a Cause of Pancreatitis by Itself But Acts as a Partner of Genetic Mutations](https://scholariq.org/papers/pancreas-divisum-is-not-a-cause-of-pancreatitis-by-itself-but-acts-as-a-partner/)
- [Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors<sup>1</sup>](https://scholariq.org/papers/pancreatic-endocrine-tumors-tumor-blood-flow-assessed-with-perfusion-ct-reflects/)
- [KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma](https://scholariq.org/papers/kras-g12d-mutation-subtype-is-a-prognostic-factor-for-advanced-pancreatic/)
- [Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis](https://scholariq.org/papers/outcome-of-patients-with-type-1-or-2-autoimmune-pancreatitis/)
- [Long-term Outcome of Biliary and Duodenal Stents in Palliative Treatment of Patients with Unresectable Adenocarcinoma of the Head of Pancreas](https://scholariq.org/papers/long-term-outcome-of-biliary-and-duodenal-stents-in-palliative-treatment-of/)
- [Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)](https://scholariq.org/papers/pancreatic-cancer-french-clinical-practice-guidelines-for-diagnosis-treatment/)
- [Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms](https://scholariq.org/papers/digestive-system-mixed-neuroendocrine-non-neuroendocrine-neoplasms/)
- [FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide–platinum combination in patients with neuroendocrine carcinomas grade 3](https://scholariq.org/papers/folfiri-regimen-an-effective-second-line-chemotherapy-after-failure-of-etoposide/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Researcher university

- [Université Paris-Saclay](https://scholariq.org/institutions/universite-paris-saclay/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.